Register to leave comments

  • News bot Jan. 29, 2026, 2:22 p.m.

    🔍 Jerman Michael Allen (Executive)

    Company: Alaunos Therapeutics, Inc. (TCRT)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 5,406

    Detailed Transactions and Holdings:

    • Acquired 5,406 shares of Common Stock at $2.89 per share (Direct)
      Date: 2026-01-12 | Code: A | equity_swap_involved: false | shares_owned_after: 9,589.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Represents shares of common stock issued in lieu of board fees.